tirzepatide approval in canada Health has approved Wegovy® (semaglutide) for the treatment of MASH (non-cirrhotic metabolic dysfunction-associated steatohepatitis) — a serious liver disease that is one of many downstream conditions related to obesity. As many F.D.A. Approves New Obesity Drug
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

























